Apnimed, Inc. (APMD) stock
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.45−0.35 (-1.97%)
Close on Nov 18, 2026Market cap $83.79MP/E –Yield –
Apnimed net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $125.94M | – |
| Q1 FY2026 | Mar 31, 2026 | $67.72M | – |
| Q2 FY2025 | Jun 30, 2025 | -$69.47M | – |
| Q1 FY2025 | Mar 31, 2025 | -$28.65M | – |
See a number that looks wrong?